Corbus Pharmaceuticals Holdings, Inc. — Cash Flow Charts
41 quarters of history · ending 2024-09-30 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+47.3% +$7M
$-8M
Free Cash Flow↑+47.3% +$7M
$-8M
Investing Cash Flow↓-1870.1% -$104M
$-98M
Financing Cash Flow
$25M
Capex
$0
Stock-Based Comp↑+173.2% +$1M
$2M
Debt Issued
$19M
D&A↓-24.0% -$48K
$152K
SBC Allocated Expense↓-99.7% -$819K
$2K
SBC Unrecognized Cost
$1M